ElMindA was founded in 2006, with the vision of revolutionizing the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice, opening a new window into our brain’s functionality, and enabling well-informed clinical decision making.
Our mission is to bring to market a paradigm changing platform technology for daily practical use that will:
ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.
Latest funding size
Time since last funding
|about 2 years|
|Wexford Capital, Palisade Capital Management, WR Hambrecht, LLC, The R-Group, Kraft Group, Shanda Group|